|
1
|
Nair MS, Mony U, Menon D, Koyakutty M,
Sidharthan N, Pavithran K, Nair SV and Menon KN: Development and
molecular characterization of polymeric micro-nanofibrous scaffold
of a defined 3-D niche for in vitro chemosensitivity analysis
against acute myeloid leukemia cells. Int J Nanomedicine.
10:3603–3622. 2015.PubMed/NCBI
|
|
2
|
Funayama K, Murai F, Shimane M, Nomura H
and Asano S: Adhesion-induced drug resistance in leukemia stem
cells. Pharmacology. 86:79–84. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wojtkowiak JW, Verduzco D, Schramm KJ and
Gillies RJ: Drug resistance and cellular adaptation to tumor acidic
pH microenvironment. Mol Pharm. 8:2032–2038. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang JY, Yu P, Chen S, Xing H, Chen Y,
Wang M, Tang K, Tian Z, Rao Q and Wang J: Activation of Rac1 GTPase
promotes leukemia cell chemotherapy resistance, quiescence and
niche interaction. Mol Oncol. 7:907–916. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dumbleton J, Agarwal P, Huang H, Hogrebe
N, Han R, Gooch KJ and He X: The effect of RGD peptide on 2D and
miniaturized 3D culture of HEPM cells, MSCs, and ADSCs with
alginate hydrogel. Cell Mol Bioeng. 9:277–288. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Duval K, Grover H, Han LH, Mou Y, Pegoraro
AF, Fredberg J and Chen Z: Modeling physiological events in 2D vs.
3D cell culture. Physiology (Bethesda). 32:266–277. 2017.PubMed/NCBI
|
|
7
|
Nugraha B, Mohr MA, Ponti A, Emmert MY,
Weibel F, Hoerstrup SP, Moll S, Certa U, Prunotto M and Pantazis P:
Monitoring and manipulating cellular crosstalk during kidney
fibrosis inside a 3D in vitro co-culture. Sci Rep. 7:144902017.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hou J, Hong Z, Feng F, Chai Y, Zhang Y,
Jiang Q, Hu Y, Wu S, Wu Y, Gao X, et al: A novel chemotherapeutic
sensitivity-testing system based on collagen gel droplet embedded
3D-culture methods for hepatocellular carcinoma. BMC Cancer.
17:7292017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Burton TP, Corcoran A and Callanan A: The
effect of electrospun polycaprolactone scaffold morphology on human
kidney epithelial cells. Biomed Mater. 13:0150062017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Caicedo-Carvajal CE, Liu Q, Remache Y, Goy
A and Suh KS: Cancer tissue engineering: A novel 3D polystyrene
scaffold for in vitro isolation and amplification of lymphoma
cancer cells from heterogeneous cell mixtures. J Tissue Eng.
2011:3623262011.PubMed/NCBI
|
|
11
|
Hur H, Ham IH, Lee D, Jin H, Aguilera KY,
Oh HJ, Han SU, Kwon JE, Kim YB, Ding K, et al: Discoidin domain
receptor 1 activity drives an aggressive phenotype in gastric
carcinoma. BMC Cancer. 17:872017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Moreau V and Saltel F: Type I collagen
fibrils and discoidin domain receptor 1 set invadosomes straight.
Mol Cell Oncol. 2:e10049632015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Stępnik M, Spryszyńska S, Gorzkiewicz A
and Ferlińska M: Cytotoxicity of anticancer drugs and PJ-34
(poly(ADP-ribose)polymerase-1 (PARP-1) inhibitor) on HL-60 and
Jurkat cells. Adv Clin Exp Med. 26:379–385. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Blanco TM, Mantalaris A, Bismarck A and
Panoskaltsis N: The development of a three-dimensional scaffold for
ex vivo biomimicry of human acute myeloid leukaemia. Biomaterials.
31:2243–2251. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bao M, Xie J, Piruska A and Huck WTS: 3D
microniches reveal the importance of cell size and shape. Nat
Commun. 8:19622017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bell CC, Dankers ACA, Lauschke VM,
Sison-Young R, Jenkins R, Rowe C, Goldring CE, Park K, Regan SL,
Walker T, et al: Comparison of hepatic 2D sandwich cultures and 3D
spheroids for long-term toxicity applications: A multi-center
study. Toxicol Sci. 162:655–666. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xue R, Qian Y, Li L, Yao G, Yang L and Sun
Y: Polycaprolactone nanofiber scaffold enhances the osteogenic
differentiation potency of various human tissue-derived mesenchymal
stem cells. Stem Cell Res Ther. 8:1482017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yildirim ED, Besunder R, Pappas D, Allen
F, Güçeri S and Sun W: Accelerated differentiation of osteoblast
cells on polycaprolactone scaffolds driven by a combined effect of
protein coating and plasma modification. Biofabrication.
2:0141092010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Das S, Ongusaha PP, Yang YS, Park JM,
Aaronson SA and Lee SW: Discoidin domain receptor 1 receptor
tyrosine kinase induces cyclooxygenase-2 and promotes
chemoresistance through nuclear factor-kappaB pathway activation.
Cancer Res. 66:8123–8130. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Canning P, Tan L, Chu K, Lee SW, Gray NS
and Bullock AN: Structural mechanisms determining inhibition of the
collagen receptor DDR1 by selective and multi-targeted type II
kinase inhibitors. J Mol Biol. 426:2457–2470. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kim HG, Tan L, Weisberg EL, Liu F, Canning
P, Choi HG, Ezell SA, Wu H, Zhao Z, Wang J, et al: Discovery of a
potent and selective DDR1 receptor tyrosine kinase inhibitor. ACS
Chem Biol. 8:2145–2150. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fang Y, Wang B, Zhao Y, Xiao Z, Li J, Cui
Y, Han S, Wei J, Chen B, Han J, et al: Collagen scaffold
microenvironments modulate cell lineage commitment for
differentiation of bone marrow cells into regulatory dendritic
cells. Sci Rep. 7:420492017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lin CH, Chiang MC and Chen YJ: STAT3
mediates resistance to anoikis and promotes invasiveness of
nasopharyngeal cancer cells. Int J Mol Med. 40:1549–1556. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang JC, Zhang Y, He SJ, Li MM, Cai XL,
Wang H, Xu LM and Cao J: TM4SF1 promotes metastasis of pancreatic
cancer via regulating the expression of DDR1. Sci Rep. 7:458952017.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gao H, Chakraborty G, Zhang Z, Akalay I,
Gadiya M, Gao Y, Sinha S, Hu J, Jiang C, Akram M, et al:
Multi-organ site metastatic reactivation mediated by non-canonical
discoidin domain receptor 1 signaling. Cell. 166:47–62. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang Z, Sun X, Bao Y, Mo J, Du H, Hu J and
Zhang X: E2F1 silencing inhibits migration and invasion of
osteosarcoma cells via regulating DDR1 expression. Int J Oncol.
51:1639–1650. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang C and Zhang X: Incidence survey of
leukemia in China. Chin Med Sci J. 6:65–70. 1991.PubMed/NCBI
|
|
28
|
Broxterman HJ and Georgopapadakou NH:
Anticancer therapeutics: ‘Addictive’ targets, multi-targeted drugs,
new drug combinations. Drug Resist Updat. 8:183–197. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Da Costa EM, McInnes G, Beaudry A and
Raynal NJ: DNA methylation-targeted drugs. Cancer J. 23:270–276.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jamison C, Nelson D, Eren M, Gauchan D,
Ramaekers R, Norvell M and Copur MS: What is the optimal dose and
schedule for dasatinib in chronic myeloid leukemia: Two case
reports and review of the literature. Oncol Res. 23:1–5. 2015.
View Article : Google Scholar
|
|
31
|
Wang JZ, Zhu YX, Ma HC, Chen SN, Chao JY,
Ruan WD, Wang D, Du FG and Meng YZ: Developing multi-cellular tumor
spheroid model (MCTS) in the chitosan/collagen/alginate (CCA)
fibrous scaffold for anticancer drug screening. Mater Sci Eng C.
62:215–225. 2016. View Article : Google Scholar
|
|
32
|
Poulos MG, Gars EJ, Gutkin MC, Kloss CC,
Ginsberg M, Scandura JM, Rafii S and Butler JM: Activation of the
vascular niche supports leukemic progression and resistance to
chemotherapy. Exp Hematol. 42:976–986.e3. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Prieto-Vila M, Takahashi RU, Usuba W,
Kohama I and Ochiya T: Drug resistance driven by cancer stem cells
and their niche. Int J Mol Sci. 18:25742017. View Article : Google Scholar
|
|
34
|
Feng Q, Chai C, Jiang XS, Leong KW and Mao
HQ: Expansion of engrafting human hematopoietic stem/progenitor
cells in three-dimensional scaffolds with surface-immobilized
fibronectin. J Biomed Mater Res A. 78:781–791. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Deng Y, Zhao F, Hui L, Li X, Zhang D, Lin
W, Chen Z and Ning Y: Suppressing miR-199a-3p by promoter
methylation contributes to tumor aggressiveness and cisplatin
resistance of ovarian cancer through promoting DDR1 expression. J
Ovarian Res. 10:502017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Carbone A and Gloghini A: Activated DDR1
increases RS cell survival. Blood. 122:4152–4154. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kim MK, Kim Y, Choo H and Chong Y:
Quercetin-glutamic acid conjugate with a non-hydrolysable linker; a
novel scaffold for multidrug resistance reversal agents through
inhibition of P-glycoprotein. Bioorg Med Chem. 25:1219–1226. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yang Z and Zhao X: A 3D model of ovarian
cancer cell lines on peptide nanofiber scaffold to explore the
cell-scaffold interaction and chemotherapeutic resistance of
anticancer drugs. Int J Nanomedicine. 6:303–310. 2011. View Article : Google Scholar : PubMed/NCBI
|
